MedTrace Logo

Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma.

NCT06165718 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2023-12-15

No results posted yet for this study

Summary

This is an observational study in which patients with pulmonary artery sarcoma were followed up for at least 36 months and survival was investigated.

Conditions

  • Pulmonary Artery Sarcoma

Sponsors & Collaborators

  • The First Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER

  • Beijing Chao Yang Hospital

    collaborator OTHER

  • Shanghai Pulmonary Hospital, Shanghai, China

    collaborator OTHER

  • Sir Run Run Shaw Hospital

    collaborator OTHER

  • Beijing Anzhen Hospital

    collaborator OTHER

  • China-Japan Friendship Hospital

    lead OTHER

Principal Investigators

  • Wanmu Xie · China-Japan Friendship Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-31
Primary Completion
2024-12-31
Completion
2025-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06165718 on ClinicalTrials.gov